Activation or inactivation mechanism of brain cdc2-like kinase, cdk5
Activation or inactivation mechanism of brain cdc2-like kinase, cdk5
批准号:
09480191
负责人:
HISANAGA Shin-ichi
金额:
$8.45万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cyclin-dependent kinases are key factors in progression of cell cycle in eukaryotic cells. CDK5 is an unique CDK whosc kinase activity is detected only in post-mitotic neurons. Several lines of evidence suggest that CDK5 involves in neuronal migration or positioning during development via phosphorylation of axonal cytoskeletons such as microtubule-associated protein tau and neurofilaments. However, it is not known how its kinase activity is regulated. We investigated here the activation or inactivation mechanism of CDK5.1. We studied the activation mechanism of CDK5 in primary cultured neurons using the phosphorylation of neurofilament-H subunit as a marker. CDK5 was activated at 4 to 5 days after plating when phosphorylated form of neurofilament-H subunit appeared and synapse formation occurred. Addition of BDNF into culture medium induced activation of CDK5. These results suggest that activation of CDK5 was induced by increased secretion of BDNF after synapse formation.2. CDK5 is activated by binding to activating subunit p35 which is expressed in neurons exclusively. p35 is a short life protein degraded in a few hours. CDK5 decreased its activity along with degradation of p35. p35 was degraded by proteasome as well as cyclins in proliferating cells. Phosphorylation was suggested to be a signal for degradation.3. p35 is proteolysed to p25 during purification of CDK5 from bovine or porcine brains. Proteases involving in this limited proteolysis was shown to be calpain. Addition of CaィイD12+ィエD1 to porcine brain extract induced proteolysis of p35 to p25. This proteolysis was suppressed by calpain inhibitor. The proteolysis changed the solubility of CDK5. P35/CDK5 precipitated by brief centrifugation became to be soluble after proteolytic conversion to p25. Limited proteolysis of p35 to p25 was enhanced at the time of neuronal cell death.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
久永真市: "分子生物学 田沼靖一編、共著"丸善. 16 (1999)
Makoto Hisanaga:“田沼精一编辑和合着的分子生物学”Maruzen 16 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
久永真市: "ロータリーシャドウイング-繊維状蛋白の観察に優れたグリセリン・スプレイ法"細胞工学 16. 8 (1997)
Makoto Hisanaga:“旋转阴影 - 甘油喷雾法非常适合观察纤维蛋白”Cell Engineering 16. 8 (1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
斎藤太郎: "プロティンフォスファターゼによる中間径フィラメントの機能制御" 蛋白質・核酸・酵素. 43. 76-83 (1998)
Taro Saito:“蛋白质磷酸酶对中间丝的功能控制”《蛋白质/核酸/酶》43. 76-83 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Honma et al.: "Phosphorylation of retinablastoma protain at apoptptic cell death in rat neuroblastoma B50 cells"Neurosci.Lett.. 235. 45-48 (1997)
Honma 等:“大鼠神经母细胞瘤 B50 细胞凋亡时视网膜母细胞瘤蛋白的磷酸化”Neurosci.Lett.. 235. 45-48 (1997)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kusakawa et al.: "Ser787 in the proline-rich region of human MAP4 is a critical phosphorylation site that reduces the microtubule polymerization activity"Cell Struct.Funct.. (in press).
Kusakawa 等人:“人 MAP4 富含脯氨酸区域的 Ser787 是降低微管聚合活性的关键磷酸化位点”Cell Struct.Funct..(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 32 条
Regulation of endosome formation and recycling by Cdk5/p35 in neurons
-
批准号:20370047
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2008
-
负责人:HISANAGA Shin-ichi
-
依托单位:
Regulation of Cdk5 activity and function in neurons
-
批准号:17300119
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.65万
-
财政年份:2005
-
负责人:HISANAGA Shin-ichi
-
依托单位:
The novel function of cyclin-dependent kinase 5, a role in long term potentiation
-
批准号:14580703
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2002
-
负责人:HISANAGA Shin-ichi
-
依托单位:
The regulation mechanism of degradation of p35 CDK5 activation subunit in neurons
-
批准号:12680700
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2000
-
负责人:HISANAGA Shin-ichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于力学微环境探讨ERK/CDK5/P-MIEF1轴阻滞AECII分化在肺纤维化中的作用及机制研究
-
批准号:2026JJ60258
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邵敏
-
依托单位:
USP4/Fbxw7通过稳定CDK5促进线粒体裂变进而通过重塑谷氨酰胺代谢介导胃癌曲妥珠单抗耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:黎晖
-
依托单位:
圣草酚靶向结合PSA稳定CDK5激活Nrf2信号抑制铁死亡的抗AD机制
研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李文军
-
依托单位:
基于 CDK5/P35 信号通路探究脊髓水平去甲肾
上腺素能神经元调控慢性神经病理性疼痛潜
在的临床应用机制研究
-
批准号:HZY24H090005
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:沈悦
-
依托单位:
蕊木属植物中新颖CDK5抑制剂的发现及其抗阿尔兹海默病活性研究
-
批准号:32370426
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:张于
-
依托单位:
高选择性CDK5抑制剂的设计、合成及其抗常染色体显性多囊肾病的活性研究
-
批准号:82304273
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陆征宇
-
依托单位:
基于“肺与大肠相表里”理论对清胰汤调控CDK5/NFAT5-MARK4信号通路重塑细胞微管骨架减轻重症急性胰腺炎时肺微血管内皮损伤的实验研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈海龙
-
依托单位:
内侧前额叶皮质Cdk5协同GSK3β通过磷酸化上调SynapsinⅡ表达抑制慢性神经病理性疼痛的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:钱怡玲
-
依托单位:
高活性CDK5/p25磷酸化Mcm2启动DNA复制通路导致垂体腺瘤发生的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:胡亚芳
-
依托单位:
年轻血清介导血管内皮细胞Cdk5负调控高反应性中性粒细胞浸润入脑减轻Alzheimer’s病的机制研究
-
批准号:82271473
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:祁方昉
-
依托单位: